-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Cap-dependent-endonuclease-IN-17
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2649362-71-8.gif)
| Category | Influenza Virus |
| CAS | 2649362-71-8 |
| Description | Cap-dependent endonuclease-IN-17 is a cap-dependent endonuclease (CEN) inhibitor. Cap-dependent endonuclease-IN-17 shows antiviral activity against influenza virus A/Hanfang/359/95 (H3N2) with IC50 of 1.29 μM. |
Product Information
| Synonyms | Cap-dependent endonuclease-IN-17|HY-143771|CS-0375159 |
| Molecular Weight | 563.5 |
| Molecular Formula | C24H20F2N3O7PS |
| Canonical SMILES | C1COCC2N1C(=O)C3=C(C(=O)C=CN3N2C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)OP(=O)(O)O |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1100 |
| Exact Mass | 563.07276448 |
| Target | Influenza Virus |
| XLogP3-AA | -0.5 |
